eGenesis
PrivateLast Round
Series D
9/4/2024
Total Funding Raised
$454M
Company Overview
Egenesis is a biotechnology company that specializes in gene editing and genome engineering to revolutionize solid organ and therapeutic cell transplantation for life-threatening diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
eGenesis Comps
Public and private peers based on sector, stage, and business model.
eGenesis Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | 9/4/2024 | ||||
| Series C | 3/2/2021 | ||||
| Series B | 11/7/2019 | ||||
| Series A | 3/16/2017 |
Key People
Founding team and executive leadership
eGenesis Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SymBiosis Capital Management | Series C |
| Farallon Capital Management | Series D, Series C |
| LifeSci Venture Partners | Series C |
| Khosla Ventures | Series D, Series B, Series A, Series C |
| Eisai Innovation | Series D |
| Altium Capital | Series C |
| Osage University Partners | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 18, 2026
Conducting clinical study for EGEN-2784 at Massachusetts General Hospital.
- Mar 24, 2026
Named to Fast Company's World's Most Innovative Companies list for 2026.
eGenesis Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about eGenesis's valuation, stock price, and market status.
